Codexis, Inc., incorporated in Delaware in January 2002, is a leading provider of technology solutions dedicated to improving the manufacture of therapeutic drugs. The Company utilizes its proprietary CodeEvolver directed evolution technology platform to discover, develop, enhance and commercialize novel high-performance enzymes and other types of proteins. These enzymes are indispensable biomolecules in almost all biochemical reactions and can be engineered to give them specific functions and properties. Codexis applies its technology and expertise to improve the properties and performance of enzymes and drives significant advancements in the production process of complex therapeutic drugs through its ECO synthesis platform and small molecule drug biocatalysis business.
